Prospective acceptability of digital therapy for major depressive disorder in France: multicentric real-life study.
Fiche publication
Date publication
avril 2024
Journal
JMIR formative research
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HAFFEN Emmanuel
Tous les auteurs :
Amiot O, Sauvaget A, Alamome I, Bulteau S, Charpeaud T, Clair AH, Courtet P, Drapier D, Haffen E, Fakra E, Christian GB, Gourion-Gaillard A, Mouchabac S, Pineau F, Narboni V, Duburcq A, Lecardeur L
Lien Pubmed
Résumé
Major depressive disorder is one of the leading causes of disability worldwide. Recently, the WHO has highlighted the negative impact of recent crises (COVID-19 pandemic, war in Ukraine, economic crisis). Although most international guidelines recommend psychological and psychosocial interventions as a first-line treatment for mild to moderate depression, access remains limited in France due to limited availability of trained clinicians, high costs for patients in a context of non-reimbursement and fear of stigmatisation. Therefore, online blended psychological treatment such as deprexis® could improve access to care for people with depression. It has several advantages such as easy access, scalability and is supported by evidence.
Référence
JMIR Form Res. 2024 04 3;: